Needham & Company Reiterates Jazz Pharmaceuticals (JAZZ) at Buy Following Sunosi Deal, Sees it as a Positive
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 214.00 -0.65 (0.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.65 | 52 Week High | $160.00 | |||
| Open | $213.09 | 52 Week Low | $95.80 | |||
| Day High | $215.35 | P/E | 39.78 | |||
| Day Low | $211.49 | EPS | $5.38 | |||
| Volume | 560,600 | |||||
